The FDA's latest update to its list of discontinued medical devices includes products from Cardinal Health and Intuity ...

Pharmacists may continue making compounded versions of the weight-loss medication tirzepatide while the U.S. Food and Drug ...

The Food and Drug Administration (FDA) said it will reconsider its decision to remove Eli Lilly’s blockbuster weight loss and ...

The U.S. Food and Drug Administration on Friday agreed to reconsider a decision it made last month to bar drug compounders ...

The Food and Drug Administration (FDA) on Friday declared shortages of three intravenous drugs produced at a North Carolina ...

Pharmacists can continue making compounded versions of generic tirzepatide, the active ingredient in popular medications ...

Forty years after the Hatch-Waxman Act created a market for affordable generic versions of prescription medications, ...

The FDA said in a court filing late Friday that it would allow pharmacists to continue making compounded versions of ...

The US regulator has said that compounders can continue to trade in tirzepatide products while it undertakes a review to ...

Eli Lilly (LLY) is calling on companies that have been selling off-brand versions of its popular diabetes and weight-loss ...

Eli Lilly has finally made enough supply of its popular medicine tirzepatide to meet soaring demand, which should help the ...

A trade group representing compounding pharmacies sued the FDA for a “reckless and arbitrary” decision to remove Eli Lilly's ...